May 2, 2019
E-Update – CB2 ANNOUNCES FULL YEAR 2018 Financial Results AFTER A TRANSFORMATIVE YEAR
Jamie Blundell, President & COO is pleased to provide the following update on CB2, one of CGOC’s public holdings:
CB2 Insights (“CB2”) (CSE: CBII), one of CGOC’s public portfolio holdings, announced fourth quarter and full year financial results for the period ending December 31, 2018, within their earnings release issued yesterday, April 30, 2019 (to read the full press release click here).
CB2’s management team held a conference call to discuss their 2018 Year End Earnings on May 1, 2019, at 4:00pm ET. An archived replay of the conference is available by dialing 1-800-319-6413 and using the Replay Access Code 3220.
Sign up here to be included in our email blasts and receive timely updates.
For further information please contact Cannabis Growth Opportunity Corporation:
|Website: www.cgocorp.com||Investor Relations Email: email@example.com|
CB2 Insights has a mission to mainstream medical cannabis into traditional healthcare. We do so by gathering data and creating objective real-world evidence through our proprietary software and service brands. Using clinical management and data collection software at the point-of-care, CB2 Insights and its group of sub-brands has become a leading force behind bringing traditional healthcare protocols to the rapidly evolving global cannabis industry.
For more information please visit www.cb2insights.com.